38.46
+0.73%
Close of 9 Nov 2026, in SAR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Al-Dawaa Medical Services
Its shares trade on Tadawul under the ticker 4163.SR. It has been listed since 14 March 2022. In the fiscal year to 31 December 2025, it reported revenue of SAR 6.74bn and net income of SAR 321.8m. At that date it held total assets of SAR 5.23bn and shareholders' equity of SAR 1.45bn.
Al Dawaa Medical Services Co. wholesales and retails pharmaceutical products. The company is headquartered in Al Khubar, Eastern Province. The company went IPO on 2022-03-14. The firm operates through six divisions which includes Beauty Care, Personal Care, Health & Wellness, Medicine & Treatments, Mum and Baby and Vitamins & Healthy Nutrition. Beauty Care division engaged in selling Beauty Accessories, Contact Lenses, Perfumes, Hair and Face Care, etc. Personal Care products includes Body & Skin Care, Deodorants, Hand & Foot Care products, Oral Care. Health & Wellness products are Medical Devices, Geriatric Care, Braces & Supports, Home Care Products, Sports & Fitness products. Medicine & Treatments products provides Pain Relief medicines, Cough, Cold & Allergy medicines, Dental & Oral Hygiene, Kids & Infants and Prescribed Medications. Mum and Baby products include a range of mother and baby products. Vitamins & Healthy Nutrition products provides Men Vitamins & Supplements, Healthy Food, Bone Health, etc.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Consumer Staples
- Industry
- Consumer Staples Distribution & Retail
- Listed since
- 14 Mar 2022
- Employees
- 6,014
- Website
- al-dawaa.com ↗
Leadership
Pay as last reported
- Mr. Samir Mahmood Fayyad AbdulhadiNon-Executive Chairman of the Board
- Mr. Mohammed Saad Butti Al-Farraj Al-SubaieChief Executive Officer, Executive Member of the Board, since 2021
- Mr. Ibrahim Salem Muhammad Al-RuwaisIndependent Non-Executive Deputy Chairman of the Board
- Mr. Shareef Ahmed Al-AqabawiChief Financial Officer, Director - Financial Affairs, since 2023
- Mr. Fahad Abdullah Saad Al-FarajExecutive Vice President
- Mr. Waleed Mohammad Abdullah Al-JaafarManaging Director, Executive Member of the Board, since 2021
- Mr. Hamad Mohammed Mubarak Al-HuthailiNon-Executive Member of the Board
- Mr. Hassan Abdullah Durar Al-SomaliIndependent Member of the Board
- Mr. Mahmoud Marzouk TahaInvestor Relations
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Operates through six divisions covering diverse product categories including Beauty Care and Health & Wellness.
- Headquartered in Al Khubar, Eastern Province, with a focus on pharmaceutical retail and wholesale.
- IPO in 2022-03-14 indicates established market presence and financial structure.
Weaknesses
- No specific weaknesses mentioned in the provided information.
- No details on employee turnover or operational inefficiencies provided.
- No financial performance metrics or market share data available.
Opportunities
- Expansion into new markets within the Consumer Staples sector.
- Growth potential in the Health & Wellness and Vitamins & Healthy Nutrition divisions.
- Increasing demand for pharmaceutical and personal care products in the region.
Threats
- Competition from other pharmaceutical retailers in the Consumer Staples sector.
- Regulatory changes affecting pharmaceutical sales and distribution.
- Economic downturns impacting consumer spending on non-essential items.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.